Singapore IPO Market Under Pressure as Nearly All 2026 New Listings Trade Below Issue Price

The Quick Take

• Almost all new listings on Singapore Exchange (SGX) in 2026 are trading below their IPO issue prices.
• Business Times' Ben Paul attributes the pattern to structural issues including low trading liquidity and limited institutional participation.
• Proposed solutions reportedly include more flexible pricing mechanisms and greater anchor investor support.

Singapore Exchange faces a persistent IPO quality challenge in 2026, with nearly all new listings from this year trading underwater relative to their issue prices. The phenomenon — dubbed an 'IPO curse' — reflects structural issues that have been building since SGX lost several major listings to Hong Kong, New York, and London over the past decade. The Business Times' senior correspondent Ben Paul's analysis suggests the problem is systemic: pricing mechanisms, insufficient pre-IPO investor discovery, and thin post-listing liquidity create a feedback loop where negative first-day returns deter subsequent issuers.

For capital markets professionals and regional IPO investors, Singapore's IPO underperformance has direct knock-on effects. SGX's ability to compete for mid-cap Southeast Asian company listings depends on its reputation as a liquidity venue. If new issuers see their predecessors trading underwater, the pipeline of future IPO candidates shifts to Bursa Malaysia, Jakarta, Bangkok, or dual-list to Hong Kong. Investment banks with Singapore listing capabilities (DBS, UOB, OCBC, Macquarie) face reduced IPO fee revenue, and anchor investor structures need rethinking.

Proposed solutions likely include cornerstone investor reforms (similar to Hong Kong's model), mandatory stabilization mechanisms, and looser pricing flexibility windows. The macro variable is the Singapore dollar's stability relative to regional currencies — a strong SGD makes Singapore-listed assets less attractive to regional investors benchmarked in local currencies, compressing relative liquidity and contributing to post-IPO drift. SGX's regulatory consultation timeline is the key near-term signal.

Synthesized from 1 source.